When evaluating and diagnosing migraines in pediatric patients, a thorough medical history is key to giving a diagnosis. These 8 questions are structured to pinpoint concerning headache patterns earlier in the diagnosing process.
Navepegritide NDA submitted to treat children with achondroplasia
Submission is based on 3 clinical trials, including data from the ApproaCH Trial among children with achondroplasia.
PODCAST: Auditory brain stem implants in young children.
Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.
New questionnaire effectively screens for PANDAS/PANS
The PANDAS/PANS questionnaire is based on symptoms and comorbidities described in the literature and is a self-report completed by parents of children younger than 18.
OAV101 in SMA patients demonstrates improved motor function, disease progression
Results were from the phase 3 STEER study among a broad population of patients with SMA aged 2 to under 18 years.
FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis
First approved for PNH in 2007, the monoclonal antibody is now the first and only treatment for pediatric patients living with gMG.
FDA accepts new drug application for vatiquinone to treat Friedreich's ataxia
The FDA has accepted PTC Therapeutics' NDA for vatiquinone, a potential treatment for Friedreich's ataxia, with a decision expected by August 19, 2025.